Newsletters

Sheep Trials: Successful Blood Vessel Formation and Scaffold Colonization

A New Era for Foregen

Year in Review: 2022

Stakeholder Report #2: Sheep Trials

5 Million Men? More Than Triple That: Over 18 Million American Men Would Consider Regenerating Their Foreskin.

Sheep Trial Stakeholder Report

There and Back Again: Biomaterials, Biocompatibility, and Foregen’s Research (Part 4)

There and Back Again: Biomaterials, Biocompatibility, and Foregen’s Research (Part 3)

There and Back Again: Biomaterials, Biocompatibility, and Foregen’s Research (Part 2)

There and Back Again: Biomaterials, Biocompatibility, and Foregen’s Research (Part 1)

Rat Model Overview

A Year in Review: 2021

Human Clinical Trial Clarification

Foregen's Human Clinical Trial

YouTube Livestream Event!

December $100,000 Matching Campaign

Tax Benefits of Crypto Donations to Foregen

What's a Histology Study?

Ahiṃsā: The Sanctity of Life

Weekly Recap October 16th, 2021

A Bridge to Heal America: How Glans Restoration Restores Immune Protection

YouGov Survey 2021

Weekly Recap September 24th, 2021

Weekly Recap September 17th, 2021

Animal Trial Update

Weekly Recap September 10th

Letter to Discover Magazine

Foreskin Arterial Endothelial Glycocalyx Essential for Organ Development, Function and Resilience.

Penile Vascular Tissue Removal Reduces Organ Capacity for Erection

A Push Beyond Africa

The Fallout of Misguided Circumcision Campaigns in Sub-Saharan Africa

International Contractors are Profiteering from New Circumcision Devices

Circumcision Stakeholders in Africa

Is Circumcision a Fraud?

Animal Model Blog

Website Refresh

COVID-19 Update